UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The double edge sword of fibrosis in cancer

Translational research : the journal of laboratory and clinical medicine, 2019-07, Vol.209, p.55-67

2019

Volltextzugriff (PDF)

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Nature communications, 2021-06, Vol.12 (1), p.3349-3349, Article 3349

2021

Volltextzugriff (PDF)

Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer

JCI insight, 2020-06, Vol.5 (11)

2020

Volltextzugriff (PDF)

Serum ferritin: Past, present and future

Biochimica et biophysica acta, 2010-08, Vol.1800 (8), p.760-769

2010

Volltextzugriff (PDF)

Ovarian Carcinoma‐Associated Mesenchymal Stem Cells Arise from Tissue‐Specific Normal Stroma

Stem cells (Dayton, Ohio), 2019-02, Vol.37 (2), p.257-269

2019

Volltextzugriff (PDF)

Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth

Oncogene, 2019-02, Vol.38 (9), p.1576-1584

2019

Volltextzugriff (PDF)

New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination

Translational research : the journal of laboratory and clinical medicine, 2016-09, Vol.175, p.92-102.e2

2016

Volltextzugriff (PDF)

An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer

Cancer research (Chicago, Ill.), 2011-11, Vol.71 (21), p.6728-6737

2011

Volltextzugriff (PDF)

Ferritin for the clinician

Blood reviews, 2009-05, Vol.23 (3), p.95-104

2009

Volltextzugriff (PDF)

Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop

Oncotarget, 2016-02, Vol.7 (6), p.6916-6932

2016

Volltextzugriff (PDF)

Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer

Cell reports (Cambridge), 2024-08, Vol.43 (8), p.114551, Article 114551

2024

Volltextzugriff (PDF)

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer

Oncotarget, 2018-03, Vol.9 (21), p.15658-15672

2018

Volltextzugriff (PDF)

Call for action: expanding global access to hereditary cancer genetic testing

The lancet oncology, 2022-09, Vol.23 (9), p.1124-1126

2022

Volltextzugriff (PDF)

Regulatory effects of ferritin on angiogenesis

Proceedings of the National Academy of Sciences - PNAS, 2009-01, Vol.106 (2), p.570-575

2009

Volltextzugriff (PDF)

Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (50), p.E6882-E6888

2015

Volltextzugriff (PDF)

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis

Cell reports (Cambridge), 2020-12, Vol.33 (10), p.108473-108473, Article 108473

2020

Volltextzugriff (PDF)

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition

Science advances, 2021-11, Vol.7 (46), p.eabi5790-eabi5790

2021

Volltextzugriff (PDF)

Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer

Cancers, 2024-01, Vol.16 (3), p.474

2024

Volltextzugriff (PDF)

Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5616

2022

Volltextzugriff (PDF)

An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis

Journal of visualized experiments, 2021-03 (169)

2021

Volltextzugriff (PDF)

Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells

Biomolecules (Basel, Switzerland), 2023-11, Vol.13 (11), p.1604

2023

Volltextzugriff (PDF)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer

JCI insight, 2022-09, Vol.7 (18)

2022

Volltextzugriff (PDF)

Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri -IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation

Cancers, 2023-03, Vol.15 (6), p.1670

2023

Volltextzugriff (PDF)

CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary

Cancers, 2019-11, Vol.11 (11), p.1710

2019

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(99)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The double edge sword of fibrosis in cancer

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma

Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer

Serum ferritin: Past, present and future

Ovarian Carcinoma‐Associated Mesenchymal Stem Cells Arise from Tissue‐Specific Normal Stroma

Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth

New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination

An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer

Ferritin for the clinician

Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop

Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer

CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer

Call for action: expanding global access to hereditary cancer genetic testing

Regulatory effects of ferritin on angiogenesis

Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis

Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progression

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition

Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer

Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22

An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis

Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer

Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri -IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation

CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary

Suchergebnisse filtern